Company news

Formosa Laboratories, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

April 30, 2026

Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

February 23, 2026

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

January 12, 2026

Formosa Pharmaceuticals Announces Licensing Agreement with Rxilient, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

December 3, 2025

Formosa Plastics Corporation, U.S.A. Unveils the Largest Horizontal Polypropylene Reactor in North America

September 23, 2025

PAK Quality Foods Has Acquired Formosa Foods

July 21, 2025

Decks